nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—MTHFR—migraine	0.337	1	CbGaD
Methotrexate—SLC16A1—Valproic Acid—migraine	0.0756	0.171	CbGbCtD
Methotrexate—ABCC10—Verapamil—migraine	0.0658	0.149	CbGbCtD
Methotrexate—ABCC3—Verapamil—migraine	0.0414	0.0934	CbGbCtD
Methotrexate—SLC22A7—Valproic Acid—migraine	0.0372	0.0839	CbGbCtD
Methotrexate—ABCC4—Verapamil—migraine	0.0316	0.0714	CbGbCtD
Methotrexate—ABCC1—Verapamil—migraine	0.0254	0.0574	CbGbCtD
Methotrexate—SLC22A8—Valproic Acid—migraine	0.0227	0.0512	CbGbCtD
Methotrexate—SLCO1A2—Verapamil—migraine	0.0227	0.0512	CbGbCtD
Methotrexate—SLCO1B1—Verapamil—migraine	0.0214	0.0483	CbGbCtD
Methotrexate—ABCC2—Verapamil—migraine	0.0188	0.0425	CbGbCtD
Methotrexate—ABCG2—Verapamil—migraine	0.017	0.0384	CbGbCtD
Methotrexate—SLC22A6—Valproic Acid—migraine	0.0158	0.0357	CbGbCtD
Methotrexate—ALB—Amitriptyline—migraine	0.0148	0.0333	CbGbCtD
Methotrexate—ABCB1—Timolol—migraine	0.01	0.0226	CbGbCtD
Methotrexate—ABCB1—Propranolol—migraine	0.00893	0.0202	CbGbCtD
Methotrexate—ABCB1—Amitriptyline—migraine	0.00772	0.0174	CbGbCtD
Methotrexate—ABCB1—Verapamil—migraine	0.00613	0.0138	CbGbCtD
Methotrexate—SLC19A1—Metabolism of folate and pterines—MTHFR—migraine	0.00258	0.0727	CbGpPWpGaD
Methotrexate—FPGS—Metabolism of folate and pterines—MTHFR—migraine	0.0022	0.0618	CbGpPWpGaD
Methotrexate—GGH—Fluoropyrimidine Activity—MTHFR—migraine	0.00174	0.0489	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism of folate and pterines—MTHFR—migraine	0.00171	0.0482	CbGpPWpGaD
Methotrexate—FOLR1—Folate Metabolism—MTHFR—migraine	0.00132	0.0371	CbGpPWpGaD
Methotrexate—Folic Acid—MTHFR—migraine	0.00113	0.5	CrCbGaD
Methotrexate—Tetrahydrofolic acid—MTHFR—migraine	0.00113	0.5	CrCbGaD
Methotrexate—MTHFR—blood vessel—migraine	0.00105	0.0259	CbGeAlD
Methotrexate—GGH—trigeminal ganglion—migraine	0.00103	0.0253	CbGeAlD
Methotrexate—DHFR—Metabolism of folate and pterines—MTHFR—migraine	0.000917	0.0258	CbGpPWpGaD
Methotrexate—FPGS—trigeminal ganglion—migraine	0.000902	0.0223	CbGeAlD
Methotrexate—ATIC—One Carbon Metabolism—MTHFR—migraine	0.000886	0.0249	CbGpPWpGaD
Methotrexate—FPGS—Fluoropyrimidine Activity—MTHFR—migraine	0.000777	0.0219	CbGpPWpGaD
Methotrexate—ATIC—brainstem—migraine	0.000772	0.0191	CbGeAlD
Methotrexate—FOLR1—head—migraine	0.000755	0.0187	CbGeAlD
Methotrexate—MTHFR—neck—migraine	0.000751	0.0185	CbGeAlD
Methotrexate—FOLR1—central nervous system—migraine	0.000689	0.017	CbGeAlD
Methotrexate—FOLR1—cerebellum—migraine	0.000674	0.0166	CbGeAlD
Methotrexate—SLC19A1—head—migraine	0.000662	0.0164	CbGeAlD
Methotrexate—TYMS—Nortriptyline—Amitriptyline—migraine	0.000657	0.553	CbGdCrCtD
Methotrexate—PGD—neck—migraine	0.000652	0.0161	CbGeAlD
Methotrexate—MTHFR—trigeminal ganglion—migraine	0.000648	0.016	CbGeAlD
Methotrexate—SLCO3A1—trigeminal ganglion—migraine	0.000638	0.0158	CbGeAlD
Methotrexate—ATIC—cardiovascular system—migraine	0.00063	0.0156	CbGeAlD
Methotrexate—SLC19A1—nervous system—migraine	0.000628	0.0155	CbGeAlD
Methotrexate—SLC19A1—central nervous system—migraine	0.000604	0.0149	CbGeAlD
Methotrexate—SLC19A1—cerebellum—migraine	0.000591	0.0146	CbGeAlD
Methotrexate—DHFR—trigeminal ganglion—migraine	0.000586	0.0145	CbGeAlD
Methotrexate—FOLR1—Folate Metabolism—TNF—migraine	0.000568	0.016	CbGpPWpGaD
Methotrexate—PGD—trigeminal ganglion—migraine	0.000563	0.0139	CbGeAlD
Methotrexate—FOLR1—brain—migraine	0.000547	0.0135	CbGeAlD
Methotrexate—TYMS—Chlorprothixene—Amitriptyline—migraine	0.000531	0.447	CbGdCrCtD
Methotrexate—SLC19A1—Folate Metabolism—MTHFR—migraine	0.000525	0.0148	CbGpPWpGaD
Methotrexate—SLC46A1—head—migraine	0.00051	0.0126	CbGeAlD
Methotrexate—GGH—head—migraine	0.000502	0.0124	CbGeAlD
Methotrexate—ALB—Scavenging of heme from plasma—LRP1—migraine	0.000498	0.014	CbGpPWpGaD
Methotrexate—AOX1—trigeminal ganglion—migraine	0.000496	0.0123	CbGeAlD
Methotrexate—ABCC11—Transmembrane transport of small molecules—TRPM8—migraine	0.000491	0.0138	CbGpPWpGaD
Methotrexate—SLC46A1—nervous system—migraine	0.000483	0.0119	CbGeAlD
Methotrexate—ABCC10—trigeminal ganglion—migraine	0.000483	0.0119	CbGeAlD
Methotrexate—SLC19A1—brain—migraine	0.00048	0.0119	CbGeAlD
Methotrexate—GGH—nervous system—migraine	0.000476	0.0118	CbGeAlD
Methotrexate—MTHFR—cardiovascular system—migraine	0.000468	0.0116	CbGeAlD
Methotrexate—SLC46A1—central nervous system—migraine	0.000465	0.0115	CbGeAlD
Methotrexate—GGH—central nervous system—migraine	0.000458	0.0113	CbGeAlD
Methotrexate—SLC46A1—cerebellum—migraine	0.000455	0.0112	CbGeAlD
Methotrexate—GGH—cerebellum—migraine	0.000448	0.0111	CbGeAlD
Methotrexate—FPGS—head—migraine	0.000441	0.0109	CbGeAlD
Methotrexate—ATIC—head—migraine	0.000427	0.0105	CbGeAlD
Methotrexate—DHFR—cardiovascular system—migraine	0.000423	0.0105	CbGeAlD
Methotrexate—SLC19A1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.000421	0.0118	CbGpPWpGaD
Methotrexate—FPGS—nervous system—migraine	0.000418	0.0103	CbGeAlD
Methotrexate—PGD—cardiovascular system—migraine	0.000407	0.01	CbGeAlD
Methotrexate—ATIC—nervous system—migraine	0.000404	0.00999	CbGeAlD
Methotrexate—FPGS—central nervous system—migraine	0.000403	0.00995	CbGeAlD
Methotrexate—SLC22A8—trigeminal ganglion—migraine	0.000397	0.00982	CbGeAlD
Methotrexate—FPGS—cerebellum—migraine	0.000393	0.00972	CbGeAlD
Methotrexate—ATIC—central nervous system—migraine	0.000389	0.00962	CbGeAlD
Methotrexate—ATIC—cerebellum—migraine	0.000381	0.0094	CbGeAlD
Methotrexate—SLC16A1—cardiovascular system—migraine	0.00038	0.00938	CbGeAlD
Methotrexate—ABCC11—Transmembrane transport of small molecules—ATP1A3—migraine	0.000372	0.0105	CbGpPWpGaD
Methotrexate—ABCC11—Transmembrane transport of small molecules—ATP1A2—migraine	0.000372	0.0105	CbGpPWpGaD
Methotrexate—DHFR—One Carbon Metabolism—MTHFR—migraine	0.00037	0.0104	CbGpPWpGaD
Methotrexate—SLC46A1—brain—migraine	0.00037	0.00913	CbGeAlD
Methotrexate—GGH—brain—migraine	0.000364	0.00898	CbGeAlD
Methotrexate—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.000358	0.0101	CbGpPWpGaD
Methotrexate—SLCO1C1—head—migraine	0.000355	0.00876	CbGeAlD
Methotrexate—SLC46A1—Folate Metabolism—MTHFR—migraine	0.000348	0.00978	CbGpPWpGaD
Methotrexate—SLCO1C1—nervous system—migraine	0.000336	0.00831	CbGeAlD
Methotrexate—DHFR—Trans-sulfuration and one carbon metabolism—MTHFR—migraine	0.000333	0.00936	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—TRPM8—migraine	0.000325	0.00916	CbGpPWpGaD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—TRPM8—migraine	0.000325	0.00916	CbGpPWpGaD
Methotrexate—DHFR—Fluoropyrimidine Activity—MTHFR—migraine	0.000324	0.00913	CbGpPWpGaD
Methotrexate—SLCO1C1—central nervous system—migraine	0.000324	0.008	CbGeAlD
Methotrexate—TYMS—One Carbon Metabolism—MTHFR—migraine	0.000323	0.00909	CbGpPWpGaD
Methotrexate—FPGS—brain—migraine	0.00032	0.0079	CbGeAlD
Methotrexate—MTHFR—head—migraine	0.000317	0.00783	CbGeAlD
Methotrexate—ABCC11—Transmembrane transport of small molecules—HTR3A—migraine	0.000317	0.00891	CbGpPWpGaD
Methotrexate—SLCO3A1—head—migraine	0.000312	0.00771	CbGeAlD
Methotrexate—ATIC—brain—migraine	0.000309	0.00764	CbGeAlD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—TRPM8—migraine	0.000308	0.00868	CbGpPWpGaD
Methotrexate—MTHFR—nervous system—migraine	0.000301	0.00743	CbGeAlD
Methotrexate—SLCO3A1—nervous system—migraine	0.000296	0.00731	CbGeAlD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—TRPM8—migraine	0.000294	0.00828	CbGpPWpGaD
Methotrexate—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—migraine	0.00029	0.00817	CbGpPWpGaD
Methotrexate—MTHFR—central nervous system—migraine	0.000289	0.00715	CbGeAlD
Methotrexate—TYMS—head—migraine	0.000289	0.00715	CbGeAlD
Methotrexate—DHFR—head—migraine	0.000286	0.00708	CbGeAlD
Methotrexate—SLCO3A1—central nervous system—migraine	0.000285	0.00704	CbGeAlD
Methotrexate—TYMS—Fluoropyrimidine Activity—MTHFR—migraine	0.000283	0.00797	CbGpPWpGaD
Methotrexate—MTHFR—cerebellum—migraine	0.000283	0.00699	CbGeAlD
Methotrexate—ABCG2—trigeminal ganglion—migraine	0.000283	0.00699	CbGeAlD
Methotrexate—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.000279	0.00784	CbGpPWpGaD
Methotrexate—SLCO3A1—cerebellum—migraine	0.000278	0.00688	CbGeAlD
Methotrexate—PGD—head—migraine	0.000275	0.0068	CbGeAlD
Methotrexate—PGD—NRF2 pathway—SLC6A4—migraine	0.000275	0.00774	CbGpPWpGaD
Methotrexate—TYMS—nervous system—migraine	0.000274	0.00678	CbGeAlD
Methotrexate—SLC22A7—Fluoropyrimidine Activity—MTHFR—migraine	0.000273	0.0077	CbGpPWpGaD
Methotrexate—DHFR—nervous system—migraine	0.000272	0.00671	CbGeAlD
Methotrexate—TYMS—central nervous system—migraine	0.000264	0.00652	CbGeAlD
Methotrexate—DHFR—central nervous system—migraine	0.000261	0.00646	CbGeAlD
Methotrexate—PGD—nervous system—migraine	0.000261	0.00645	CbGeAlD
Methotrexate—TYMS—cerebellum—migraine	0.000258	0.00638	CbGeAlD
Methotrexate—SLC16A1—head—migraine	0.000257	0.00635	CbGeAlD
Methotrexate—SLCO1C1—brain—migraine	0.000257	0.00635	CbGeAlD
Methotrexate—DHFR—cerebellum—migraine	0.000256	0.00631	CbGeAlD
Methotrexate—PGD—central nervous system—migraine	0.000251	0.00621	CbGeAlD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—TRPM8—migraine	0.000247	0.00694	CbGpPWpGaD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000247	0.00694	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—ATP1A3—migraine	0.000247	0.00694	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—ATP1A2—migraine	0.000247	0.00694	CbGpPWpGaD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000247	0.00694	CbGpPWpGaD
Methotrexate—PGD—cerebellum—migraine	0.000246	0.00607	CbGeAlD
Methotrexate—SLC16A1—nervous system—migraine	0.000244	0.00602	CbGeAlD
Methotrexate—SLC22A7—brain—migraine	0.000244	0.00602	CbGeAlD
Methotrexate—ABCC3—head—migraine	0.000237	0.00586	CbGeAlD
Methotrexate—SLC22A6—brain—migraine	0.000235	0.00581	CbGeAlD
Methotrexate—SLC16A1—central nervous system—migraine	0.000235	0.0058	CbGeAlD
Methotrexate—ABCC3—Fluoropyrimidine Activity—MTHFR—migraine	0.000234	0.0066	CbGpPWpGaD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000234	0.00658	CbGpPWpGaD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000234	0.00658	CbGpPWpGaD
Methotrexate—MTHFR—brain—migraine	0.00023	0.00568	CbGeAlD
Methotrexate—SLC16A1—cerebellum—migraine	0.000229	0.00567	CbGeAlD
Methotrexate—SLCO3A1—brain—migraine	0.000226	0.00559	CbGeAlD
Methotrexate—SLC19A1—Folate Metabolism—TNF—migraine	0.000226	0.00636	CbGpPWpGaD
Methotrexate—ABCB1—blood vessel—migraine	0.000226	0.00558	CbGeAlD
Methotrexate—ABCC3—nervous system—migraine	0.000225	0.00556	CbGeAlD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000223	0.00628	CbGpPWpGaD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000223	0.00628	CbGpPWpGaD
Methotrexate—ABCC4—Fluoropyrimidine Activity—MTHFR—migraine	0.00022	0.0062	CbGpPWpGaD
Methotrexate—ABCC3—central nervous system—migraine	0.000217	0.00535	CbGeAlD
Methotrexate—AOX1—cerebellum—migraine	0.000216	0.00535	CbGeAlD
Methotrexate—ABCC10—cerebellum—migraine	0.000211	0.0052	CbGeAlD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—HTR3A—migraine	0.00021	0.0059	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—HTR3A—migraine	0.00021	0.0059	CbGpPWpGaD
Methotrexate—TYMS—brain—migraine	0.00021	0.00518	CbGeAlD
Methotrexate—DHFR—brain—migraine	0.000208	0.00513	CbGeAlD
Methotrexate—PGD—NRF2 pathway—TGFBR2—migraine	0.000207	0.00584	CbGpPWpGaD
Methotrexate—SLCO1A2—head—migraine	0.000204	0.00503	CbGeAlD
Methotrexate—PGD—brain—migraine	0.0002	0.00493	CbGeAlD
Methotrexate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—LRP1—migraine	0.000199	0.0056	CbGpPWpGaD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—HTR3A—migraine	0.000199	0.00559	CbGpPWpGaD
Methotrexate—ABCC4—head—migraine	0.000196	0.00484	CbGeAlD
Methotrexate—SLC22A8—head—migraine	0.000194	0.0048	CbGeAlD
Methotrexate—SLCO1A2—nervous system—migraine	0.000193	0.00477	CbGeAlD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—HTR3A—migraine	0.00019	0.00534	CbGpPWpGaD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000187	0.00526	CbGpPWpGaD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000187	0.00526	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—MTHFR—migraine	0.000186	0.00525	CbGpPWpGaD
Methotrexate—SLC16A1—brain—migraine	0.000186	0.0046	CbGeAlD
Methotrexate—SLCO1A2—central nervous system—migraine	0.000186	0.00459	CbGeAlD
Methotrexate—ABCC4—nervous system—migraine	0.000186	0.00459	CbGeAlD
Methotrexate—SLC22A8—nervous system—migraine	0.000184	0.00455	CbGeAlD
Methotrexate—SLCO1A2—cerebellum—migraine	0.000182	0.00449	CbGeAlD
Methotrexate—ABCC4—central nervous system—migraine	0.000179	0.00442	CbGeAlD
Methotrexate—SLC22A8—central nervous system—migraine	0.000177	0.00438	CbGeAlD
Methotrexate—AOX1—brain—migraine	0.000176	0.00434	CbGeAlD
Methotrexate—ABCC3—brain—migraine	0.000172	0.00425	CbGeAlD
Methotrexate—ABCC10—brain—migraine	0.000171	0.00423	CbGeAlD
Methotrexate—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.000164	0.00462	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—TRPM8—migraine	0.000162	0.00456	CbGpPWpGaD
Methotrexate—ABCG2—Fluoropyrimidine Activity—MTHFR—migraine	0.000162	0.00455	CbGpPWpGaD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—HTR3A—migraine	0.000159	0.00447	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—TRPM8—migraine	0.000159	0.00447	CbGpPWpGaD
Methotrexate—SLC46A1—Folate Metabolism—TNF—migraine	0.00015	0.00421	CbGpPWpGaD
Methotrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.000149	0.00421	CbGpPWpGaD
Methotrexate—ABCC1—cerebellum—migraine	0.000149	0.00368	CbGeAlD
Methotrexate—SLCO1A2—brain—migraine	0.000147	0.00364	CbGeAlD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—TRPM8—migraine	0.000147	0.00414	CbGpPWpGaD
Methotrexate—ALB—brain—migraine	0.000147	0.00362	CbGeAlD
Methotrexate—ABCC4—brain—migraine	0.000142	0.00351	CbGeAlD
Methotrexate—SLC22A8—brain—migraine	0.000141	0.00348	CbGeAlD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—TRPM8—migraine	0.00014	0.00393	CbGpPWpGaD
Methotrexate—ABCB1—trigeminal ganglion—migraine	0.000139	0.00344	CbGeAlD
Methotrexate—SLC19A1—Metabolism—CACNA1A—migraine	0.000126	0.00355	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—TRPM8—migraine	0.000126	0.00355	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—TRPM8—migraine	0.000124	0.00348	CbGpPWpGaD
Methotrexate—ABCG2—cerebellum—migraine	0.000123	0.00305	CbGeAlD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—ATP1A2—migraine	0.000123	0.00346	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—ATP1A3—migraine	0.000123	0.00346	CbGpPWpGaD
Methotrexate—ABCC1—brain—migraine	0.000121	0.00299	CbGeAlD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—ATP1A2—migraine	0.00012	0.00339	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—ATP1A3—migraine	0.00012	0.00339	CbGpPWpGaD
Methotrexate—Erectile dysfunction—Topiramate—migraine	0.00012	0.000853	CcSEcCtD
Methotrexate—Mediastinal disorder—Timolol—migraine	0.00012	0.000853	CcSEcCtD
Methotrexate—Visual impairment—Gabapentin—migraine	0.000119	0.000849	CcSEcCtD
Methotrexate—Urticaria—Verapamil—migraine	0.000119	0.000846	CcSEcCtD
Methotrexate—Photosensitivity reaction—Topiramate—migraine	0.000119	0.000846	CcSEcCtD
Methotrexate—Nausea—Amitriptyline—migraine	0.000119	0.000845	CcSEcCtD
Methotrexate—ABCC4—Transmembrane transport of small molecules—TRPM8—migraine	0.000118	0.00333	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—LRP1—migraine	0.000118	0.00332	CbGpPWpGaD
Methotrexate—Alopecia—Timolol—migraine	0.000117	0.000836	CcSEcCtD
Methotrexate—Malaise—Valproic Acid—migraine	0.000117	0.000835	CcSEcCtD
Methotrexate—Erythema multiforme—Gabapentin—migraine	0.000117	0.000833	CcSEcCtD
Methotrexate—Vertigo—Valproic Acid—migraine	0.000117	0.000831	CcSEcCtD
Methotrexate—Asthenia—Propranolol—migraine	0.000117	0.000831	CcSEcCtD
Methotrexate—Pneumonia—Topiramate—migraine	0.000117	0.000831	CcSEcCtD
Methotrexate—ABCC3—NRF2 pathway—SLC6A4—migraine	0.000116	0.00328	CbGpPWpGaD
Methotrexate—Mental disorder—Timolol—migraine	0.000116	0.000829	CcSEcCtD
Methotrexate—Leukopenia—Valproic Acid—migraine	0.000116	0.000828	CcSEcCtD
Methotrexate—Infestation NOS—Topiramate—migraine	0.000116	0.000826	CcSEcCtD
Methotrexate—Infestation—Topiramate—migraine	0.000116	0.000826	CcSEcCtD
Methotrexate—Erythema—Timolol—migraine	0.000116	0.000824	CcSEcCtD
Methotrexate—Malnutrition—Timolol—migraine	0.000116	0.000824	CcSEcCtD
Methotrexate—Eye disorder—Gabapentin—migraine	0.000116	0.000824	CcSEcCtD
Methotrexate—Depression—Topiramate—migraine	0.000116	0.000824	CcSEcCtD
Methotrexate—Tinnitus—Gabapentin—migraine	0.000115	0.000822	CcSEcCtD
Methotrexate—Stevens-Johnson syndrome—Topiramate—migraine	0.000115	0.000819	CcSEcCtD
Methotrexate—Cardiac disorder—Gabapentin—migraine	0.000115	0.000818	CcSEcCtD
Methotrexate—Renal failure—Topiramate—migraine	0.000114	0.000812	CcSEcCtD
Methotrexate—Cough—Valproic Acid—migraine	0.000113	0.000808	CcSEcCtD
Methotrexate—Dysgeusia—Timolol—migraine	0.000113	0.000807	CcSEcCtD
Methotrexate—Stomatitis—Topiramate—migraine	0.000113	0.000805	CcSEcCtD
Methotrexate—Conjunctivitis—Topiramate—migraine	0.000113	0.000803	CcSEcCtD
Methotrexate—Immune system disorder—Gabapentin—migraine	0.000112	0.000796	CcSEcCtD
Methotrexate—Mediastinal disorder—Gabapentin—migraine	0.000111	0.000794	CcSEcCtD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—ATP1A2—migraine	0.000111	0.00314	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—ATP1A3—migraine	0.000111	0.00314	CbGpPWpGaD
Methotrexate—Diarrhoea—Propranolol—migraine	0.000111	0.000792	CcSEcCtD
Methotrexate—TYMS—Circadian rythm related genes—NPS—migraine	0.000111	0.00313	CbGpPWpGaD
Methotrexate—MTHFR—Vitamin B12 Metabolism—TNF—migraine	0.000111	0.00312	CbGpPWpGaD
Methotrexate—Chills—Gabapentin—migraine	0.000111	0.000791	CcSEcCtD
Methotrexate—Arthralgia—Valproic Acid—migraine	0.000111	0.000788	CcSEcCtD
Methotrexate—Chest pain—Valproic Acid—migraine	0.000111	0.000788	CcSEcCtD
Methotrexate—Myalgia—Valproic Acid—migraine	0.000111	0.000788	CcSEcCtD
Methotrexate—Haematuria—Topiramate—migraine	0.00011	0.000788	CcSEcCtD
Methotrexate—Hypersensitivity—Verapamil—migraine	0.00011	0.000785	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.00011	0.000782	CcSEcCtD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—TRPM8—migraine	0.00011	0.00309	CbGpPWpGaD
Methotrexate—ABCC4—NRF2 pathway—SLC6A4—migraine	0.000109	0.00308	CbGpPWpGaD
Methotrexate—Epistaxis—Topiramate—migraine	0.000109	0.000779	CcSEcCtD
Methotrexate—Alopecia—Gabapentin—migraine	0.000109	0.000779	CcSEcCtD
Methotrexate—Discomfort—Valproic Acid—migraine	0.000109	0.000778	CcSEcCtD
Methotrexate—Vision blurred—Timolol—migraine	0.000109	0.000776	CcSEcCtD
Methotrexate—TYMS—Circadian rythm related genes—SLC6A4—migraine	0.000109	0.00307	CbGpPWpGaD
Methotrexate—Mental disorder—Gabapentin—migraine	0.000108	0.000772	CcSEcCtD
Methotrexate—Agranulocytosis—Topiramate—migraine	0.000108	0.000771	CcSEcCtD
Methotrexate—Erythema—Gabapentin—migraine	0.000108	0.000767	CcSEcCtD
Methotrexate—Malnutrition—Gabapentin—migraine	0.000108	0.000767	CcSEcCtD
Methotrexate—Dizziness—Propranolol—migraine	0.000107	0.000766	CcSEcCtD
Methotrexate—Asthenia—Verapamil—migraine	0.000107	0.000764	CcSEcCtD
Methotrexate—FPGS—Metabolism—CACNA1A—migraine	0.000107	0.00302	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—CACNA1A—migraine	0.000107	0.00302	CbGpPWpGaD
Methotrexate—Confusional state—Valproic Acid—migraine	0.000107	0.000762	CcSEcCtD
Methotrexate—Anaphylactic shock—Valproic Acid—migraine	0.000106	0.000755	CcSEcCtD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—ATP1A3—migraine	0.000106	0.00298	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—ATP1A2—migraine	0.000106	0.00298	CbGpPWpGaD
Methotrexate—Pruritus—Verapamil—migraine	0.000106	0.000754	CcSEcCtD
Methotrexate—Dysgeusia—Gabapentin—migraine	0.000105	0.000751	CcSEcCtD
Methotrexate—Infection—Valproic Acid—migraine	0.000105	0.00075	CcSEcCtD
Methotrexate—Haemoglobin—Topiramate—migraine	0.000105	0.000745	CcSEcCtD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—HTR3A—migraine	0.000104	0.00294	CbGpPWpGaD
Methotrexate—Back pain—Gabapentin—migraine	0.000104	0.000742	CcSEcCtD
Methotrexate—Haemorrhage—Topiramate—migraine	0.000104	0.000741	CcSEcCtD
Methotrexate—Hepatitis—Topiramate—migraine	0.000104	0.000741	CcSEcCtD
Methotrexate—Nervous system disorder—Valproic Acid—migraine	0.000104	0.000741	CcSEcCtD
Methotrexate—Vertigo—Timolol—migraine	0.000104	0.00074	CcSEcCtD
Methotrexate—Thrombocytopenia—Valproic Acid—migraine	0.000104	0.00074	CcSEcCtD
Methotrexate—Vomiting—Propranolol—migraine	0.000103	0.000736	CcSEcCtD
Methotrexate—Pharyngitis—Topiramate—migraine	0.000103	0.000736	CcSEcCtD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—TRPM8—migraine	0.000103	0.0029	CbGpPWpGaD
Methotrexate—Skin disorder—Valproic Acid—migraine	0.000103	0.000734	CcSEcCtD
Methotrexate—Urinary tract disorder—Topiramate—migraine	0.000103	0.000732	CcSEcCtD
Methotrexate—Hyperhidrosis—Valproic Acid—migraine	0.000102	0.00073	CcSEcCtD
Methotrexate—Rash—Propranolol—migraine	0.000102	0.00073	CcSEcCtD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—HTR3A—migraine	0.000102	0.00288	CbGpPWpGaD
Methotrexate—Dermatitis—Propranolol—migraine	0.000102	0.000729	CcSEcCtD
Methotrexate—Diarrhoea—Verapamil—migraine	0.000102	0.000729	CcSEcCtD
Methotrexate—Urethral disorder—Topiramate—migraine	0.000102	0.000727	CcSEcCtD
Methotrexate—Vision blurred—Gabapentin—migraine	0.000101	0.000723	CcSEcCtD
Methotrexate—Anorexia—Valproic Acid—migraine	0.000101	0.00072	CcSEcCtD
Methotrexate—Cough—Timolol—migraine	0.000101	0.000719	CcSEcCtD
Methotrexate—ABCB1—cardiovascular system—migraine	0.000101	0.00249	CbGeAlD
Methotrexate—FPGS—Disease—LRP1—migraine	0.0001	0.00283	CbGpPWpGaD
Methotrexate—Visual impairment—Topiramate—migraine	0.0001	0.000715	CcSEcCtD
Methotrexate—ABCG2—brain—migraine	0.0001	0.00248	CbGeAlD
Methotrexate—ABCC2—Transmembrane transport of small molecules—TRPM8—migraine	9.99e-05	0.00281	CbGpPWpGaD
Methotrexate—Ill-defined disorder—Gabapentin—migraine	9.99e-05	0.000712	CcSEcCtD
Methotrexate—Anaemia—Gabapentin—migraine	9.95e-05	0.000709	CcSEcCtD
Methotrexate—Hypotension—Valproic Acid—migraine	9.9e-05	0.000706	CcSEcCtD
Methotrexate—Dizziness—Verapamil—migraine	9.88e-05	0.000704	CcSEcCtD
Methotrexate—ABCC1—Transmembrane transport of small molecules—TRPM8—migraine	9.87e-05	0.00278	CbGpPWpGaD
Methotrexate—Arthralgia—Timolol—migraine	9.84e-05	0.000701	CcSEcCtD
Methotrexate—Myalgia—Timolol—migraine	9.84e-05	0.000701	CcSEcCtD
Methotrexate—Chest pain—Timolol—migraine	9.84e-05	0.000701	CcSEcCtD
Methotrexate—Erythema multiforme—Topiramate—migraine	9.84e-05	0.000701	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	9.77e-05	0.000697	CcSEcCtD
Methotrexate—Discomfort—Timolol—migraine	9.72e-05	0.000693	CcSEcCtD
Methotrexate—Eye disorder—Topiramate—migraine	9.72e-05	0.000693	CcSEcCtD
Methotrexate—Malaise—Gabapentin—migraine	9.71e-05	0.000692	CcSEcCtD
Methotrexate—Tinnitus—Topiramate—migraine	9.7e-05	0.000691	CcSEcCtD
Methotrexate—Vertigo—Gabapentin—migraine	9.67e-05	0.000689	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Valproic Acid—migraine	9.65e-05	0.000688	CcSEcCtD
Methotrexate—Cardiac disorder—Topiramate—migraine	9.65e-05	0.000688	CcSEcCtD
Methotrexate—Nausea—Propranolol—migraine	9.65e-05	0.000688	CcSEcCtD
Methotrexate—Leukopenia—Gabapentin—migraine	9.63e-05	0.000687	CcSEcCtD
Methotrexate—Insomnia—Valproic Acid—migraine	9.58e-05	0.000683	CcSEcCtD
Methotrexate—ABCC3—Transmembrane transport of small molecules—ATP1A3—migraine	9.55e-05	0.00269	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—ATP1A2—migraine	9.55e-05	0.00269	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—HTR7—migraine	9.54e-05	0.00268	CbGpPWpGaD
Methotrexate—Paraesthesia—Valproic Acid—migraine	9.51e-05	0.000678	CcSEcCtD
Methotrexate—Confusional state—Timolol—migraine	9.51e-05	0.000678	CcSEcCtD
Methotrexate—Vomiting—Verapamil—migraine	9.5e-05	0.000677	CcSEcCtD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—HTR3A—migraine	9.47e-05	0.00267	CbGpPWpGaD
Methotrexate—Dyspnoea—Valproic Acid—migraine	9.45e-05	0.000673	CcSEcCtD
Methotrexate—Angiopathy—Topiramate—migraine	9.44e-05	0.000673	CcSEcCtD
Methotrexate—Anaphylactic shock—Timolol—migraine	9.43e-05	0.000672	CcSEcCtD
Methotrexate—Rash—Verapamil—migraine	9.42e-05	0.000672	CcSEcCtD
Methotrexate—Somnolence—Valproic Acid—migraine	9.42e-05	0.000671	CcSEcCtD
Methotrexate—Dermatitis—Verapamil—migraine	9.41e-05	0.000671	CcSEcCtD
Methotrexate—Immune system disorder—Topiramate—migraine	9.4e-05	0.00067	CcSEcCtD
Methotrexate—Cough—Gabapentin—migraine	9.39e-05	0.000669	CcSEcCtD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—TRPM8—migraine	9.38e-05	0.00264	CbGpPWpGaD
Methotrexate—Mediastinal disorder—Topiramate—migraine	9.37e-05	0.000668	CcSEcCtD
Methotrexate—Infection—Timolol—migraine	9.37e-05	0.000668	CcSEcCtD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—ATP1A2—migraine	9.37e-05	0.00264	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—ATP1A3—migraine	9.37e-05	0.00264	CbGpPWpGaD
Methotrexate—Headache—Verapamil—migraine	9.36e-05	0.000667	CcSEcCtD
Methotrexate—Chills—Topiramate—migraine	9.33e-05	0.000665	CcSEcCtD
Methotrexate—Dyspepsia—Valproic Acid—migraine	9.33e-05	0.000665	CcSEcCtD
Methotrexate—Convulsion—Gabapentin—migraine	9.33e-05	0.000665	CcSEcCtD
Methotrexate—Nervous system disorder—Timolol—migraine	9.25e-05	0.000659	CcSEcCtD
Methotrexate—ABCC2—NRF2 pathway—SLC6A4—migraine	9.23e-05	0.0026	CbGpPWpGaD
Methotrexate—Decreased appetite—Valproic Acid—migraine	9.21e-05	0.000657	CcSEcCtD
Methotrexate—Alopecia—Topiramate—migraine	9.19e-05	0.000655	CcSEcCtD
Methotrexate—Myalgia—Gabapentin—migraine	9.16e-05	0.000653	CcSEcCtD
Methotrexate—Arthralgia—Gabapentin—migraine	9.16e-05	0.000653	CcSEcCtD
Methotrexate—Chest pain—Gabapentin—migraine	9.16e-05	0.000653	CcSEcCtD
Methotrexate—Skin disorder—Timolol—migraine	9.16e-05	0.000653	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Valproic Acid—migraine	9.15e-05	0.000652	CcSEcCtD
Methotrexate—Fatigue—Valproic Acid—migraine	9.14e-05	0.000651	CcSEcCtD
Methotrexate—Hyperhidrosis—Timolol—migraine	9.12e-05	0.00065	CcSEcCtD
Methotrexate—Mental disorder—Topiramate—migraine	9.11e-05	0.00065	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	9.1e-05	0.000649	CcSEcCtD
Methotrexate—Pain—Valproic Acid—migraine	9.06e-05	0.000646	CcSEcCtD
Methotrexate—Erythema—Topiramate—migraine	9.05e-05	0.000645	CcSEcCtD
Methotrexate—Malnutrition—Topiramate—migraine	9.05e-05	0.000645	CcSEcCtD
Methotrexate—Discomfort—Gabapentin—migraine	9.05e-05	0.000645	CcSEcCtD
Methotrexate—MTHFR—Folate Metabolism—TNF—migraine	9.03e-05	0.00254	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—HTR3A—migraine	9e-05	0.00253	CbGpPWpGaD
Methotrexate—Anorexia—Timolol—migraine	8.99e-05	0.000641	CcSEcCtD
Methotrexate—ABCC4—Transmembrane transport of small molecules—ATP1A3—migraine	8.98e-05	0.00253	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—ATP1A2—migraine	8.98e-05	0.00253	CbGpPWpGaD
Methotrexate—Nausea—Verapamil—migraine	8.88e-05	0.000633	CcSEcCtD
Methotrexate—Dysgeusia—Topiramate—migraine	8.87e-05	0.000632	CcSEcCtD
Methotrexate—Confusional state—Gabapentin—migraine	8.86e-05	0.000631	CcSEcCtD
Methotrexate—Hypotension—Timolol—migraine	8.81e-05	0.000628	CcSEcCtD
Methotrexate—Anaphylactic shock—Gabapentin—migraine	8.78e-05	0.000626	CcSEcCtD
Methotrexate—ABCC3—NRF2 pathway—TGFBR2—migraine	8.78e-05	0.00247	CbGpPWpGaD
Methotrexate—Back pain—Topiramate—migraine	8.76e-05	0.000624	CcSEcCtD
Methotrexate—Feeling abnormal—Valproic Acid—migraine	8.73e-05	0.000622	CcSEcCtD
Methotrexate—Infection—Gabapentin—migraine	8.73e-05	0.000622	CcSEcCtD
Methotrexate—ABCG2—Transmembrane transport of small molecules—TRPM8—migraine	8.69e-05	0.00245	CbGpPWpGaD
Methotrexate—Gastrointestinal pain—Valproic Acid—migraine	8.66e-05	0.000618	CcSEcCtD
Methotrexate—Nervous system disorder—Gabapentin—migraine	8.61e-05	0.000614	CcSEcCtD
Methotrexate—Thrombocytopenia—Gabapentin—migraine	8.6e-05	0.000613	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Timolol—migraine	8.59e-05	0.000613	CcSEcCtD
Methotrexate—Vision blurred—Topiramate—migraine	8.53e-05	0.000608	CcSEcCtD
Methotrexate—Skin disorder—Gabapentin—migraine	8.53e-05	0.000608	CcSEcCtD
Methotrexate—Insomnia—Timolol—migraine	8.53e-05	0.000608	CcSEcCtD
Methotrexate—Hyperhidrosis—Gabapentin—migraine	8.49e-05	0.000605	CcSEcCtD
Methotrexate—Paraesthesia—Timolol—migraine	8.47e-05	0.000604	CcSEcCtD
Methotrexate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	8.46e-05	0.00238	CbGpPWpGaD
Methotrexate—Urticaria—Valproic Acid—migraine	8.42e-05	0.0006	CcSEcCtD
Methotrexate—Dyspnoea—Timolol—migraine	8.41e-05	0.000599	CcSEcCtD
Methotrexate—Ill-defined disorder—Topiramate—migraine	8.4e-05	0.000599	CcSEcCtD
Methotrexate—Somnolence—Timolol—migraine	8.39e-05	0.000598	CcSEcCtD
Methotrexate—Body temperature increased—Valproic Acid—migraine	8.38e-05	0.000597	CcSEcCtD
Methotrexate—Abdominal pain—Valproic Acid—migraine	8.38e-05	0.000597	CcSEcCtD
Methotrexate—Anorexia—Gabapentin—migraine	8.37e-05	0.000597	CcSEcCtD
Methotrexate—Anaemia—Topiramate—migraine	8.37e-05	0.000597	CcSEcCtD
Methotrexate—SLC46A1—Metabolism—CACNA1A—migraine	8.35e-05	0.00235	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—ATP1A3—migraine	8.32e-05	0.00234	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—ATP1A2—migraine	8.32e-05	0.00234	CbGpPWpGaD
Methotrexate—Dyspepsia—Timolol—migraine	8.3e-05	0.000592	CcSEcCtD
Methotrexate—ABCC4—NRF2 pathway—TGFBR2—migraine	8.26e-05	0.00232	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—migraine	8.24e-05	0.00232	CbGpPWpGaD
Methotrexate—Hypotension—Gabapentin—migraine	8.21e-05	0.000585	CcSEcCtD
Methotrexate—Decreased appetite—Timolol—migraine	8.2e-05	0.000584	CcSEcCtD
Methotrexate—Malaise—Topiramate—migraine	8.17e-05	0.000582	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Timolol—migraine	8.14e-05	0.00058	CcSEcCtD
Methotrexate—Vertigo—Topiramate—migraine	8.14e-05	0.00058	CcSEcCtD
Methotrexate—Fatigue—Timolol—migraine	8.13e-05	0.00058	CcSEcCtD
Methotrexate—ABCC3—Transmembrane transport of small molecules—HTR3A—migraine	8.12e-05	0.00229	CbGpPWpGaD
Methotrexate—Leukopenia—Topiramate—migraine	8.11e-05	0.000578	CcSEcCtD
Methotrexate—Pain—Timolol—migraine	8.07e-05	0.000575	CcSEcCtD
Methotrexate—DHFR—Folate Metabolism—TNF—migraine	8.03e-05	0.00226	CbGpPWpGaD
Methotrexate—Musculoskeletal discomfort—Gabapentin—migraine	8e-05	0.00057	CcSEcCtD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—HTR3A—migraine	7.96e-05	0.00224	CbGpPWpGaD
Methotrexate—Insomnia—Gabapentin—migraine	7.94e-05	0.000566	CcSEcCtD
Methotrexate—Cough—Topiramate—migraine	7.9e-05	0.000563	CcSEcCtD
Methotrexate—Paraesthesia—Gabapentin—migraine	7.89e-05	0.000562	CcSEcCtD
Methotrexate—Convulsion—Topiramate—migraine	7.85e-05	0.000559	CcSEcCtD
Methotrexate—Dyspnoea—Gabapentin—migraine	7.83e-05	0.000558	CcSEcCtD
Methotrexate—SLC46A1—Disease—LRP1—migraine	7.82e-05	0.0022	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ATP1A2—migraine	7.82e-05	0.0022	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ATP1A3—migraine	7.82e-05	0.0022	CbGpPWpGaD
Methotrexate—Somnolence—Gabapentin—migraine	7.81e-05	0.000557	CcSEcCtD
Methotrexate—Hypersensitivity—Valproic Acid—migraine	7.81e-05	0.000556	CcSEcCtD
Methotrexate—Feeling abnormal—Timolol—migraine	7.77e-05	0.000554	CcSEcCtD
Methotrexate—Dyspepsia—Gabapentin—migraine	7.73e-05	0.000551	CcSEcCtD
Methotrexate—Gastrointestinal pain—Timolol—migraine	7.71e-05	0.00055	CcSEcCtD
Methotrexate—Myalgia—Topiramate—migraine	7.71e-05	0.00055	CcSEcCtD
Methotrexate—Arthralgia—Topiramate—migraine	7.71e-05	0.00055	CcSEcCtD
Methotrexate—Chest pain—Topiramate—migraine	7.71e-05	0.00055	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	7.66e-05	0.000546	CcSEcCtD
Methotrexate—PGD—Metabolism—CACNA1A—migraine	7.64e-05	0.00215	CbGpPWpGaD
Methotrexate—Decreased appetite—Gabapentin—migraine	7.64e-05	0.000544	CcSEcCtD
Methotrexate—ABCC4—Transmembrane transport of small molecules—HTR3A—migraine	7.63e-05	0.00215	CbGpPWpGaD
Methotrexate—Discomfort—Topiramate—migraine	7.62e-05	0.000543	CcSEcCtD
Methotrexate—SLC19A1—Disease—CALCA—migraine	7.61e-05	0.00214	CbGpPWpGaD
Methotrexate—Asthenia—Valproic Acid—migraine	7.6e-05	0.000542	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Gabapentin—migraine	7.58e-05	0.000541	CcSEcCtD
Methotrexate—Fatigue—Gabapentin—migraine	7.57e-05	0.00054	CcSEcCtD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ATP1A3—migraine	7.57e-05	0.00213	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ATP1A2—migraine	7.57e-05	0.00213	CbGpPWpGaD
Methotrexate—Pain—Gabapentin—migraine	7.51e-05	0.000535	CcSEcCtD
Methotrexate—Pruritus—Valproic Acid—migraine	7.5e-05	0.000534	CcSEcCtD
Methotrexate—Urticaria—Timolol—migraine	7.49e-05	0.000534	CcSEcCtD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ATP1A2—migraine	7.48e-05	0.00211	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ATP1A3—migraine	7.48e-05	0.00211	CbGpPWpGaD
Methotrexate—Body temperature increased—Timolol—migraine	7.46e-05	0.000532	CcSEcCtD
Methotrexate—Abdominal pain—Timolol—migraine	7.46e-05	0.000532	CcSEcCtD
Methotrexate—Confusional state—Topiramate—migraine	7.45e-05	0.000531	CcSEcCtD
Methotrexate—ABCG2—HIF-1-alpha transcription factor network—FOS—migraine	7.43e-05	0.00209	CbGpPWpGaD
Methotrexate—Infection—Topiramate—migraine	7.34e-05	0.000523	CcSEcCtD
Methotrexate—Diarrhoea—Valproic Acid—migraine	7.25e-05	0.000517	CcSEcCtD
Methotrexate—Nervous system disorder—Topiramate—migraine	7.25e-05	0.000517	CcSEcCtD
Methotrexate—Feeling abnormal—Gabapentin—migraine	7.24e-05	0.000516	CcSEcCtD
Methotrexate—Thrombocytopenia—Topiramate—migraine	7.24e-05	0.000516	CcSEcCtD
Methotrexate—Gastrointestinal pain—Gabapentin—migraine	7.18e-05	0.000512	CcSEcCtD
Methotrexate—Skin disorder—Topiramate—migraine	7.18e-05	0.000512	CcSEcCtD
Methotrexate—MTHFR—Selenium Micronutrient Network—TNF—migraine	7.17e-05	0.00202	CbGpPWpGaD
Methotrexate—PGD—Disease—LRP1—migraine	7.16e-05	0.00201	CbGpPWpGaD
Methotrexate—Hyperhidrosis—Topiramate—migraine	7.14e-05	0.000509	CcSEcCtD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ATP1A3—migraine	7.11e-05	0.002	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ATP1A2—migraine	7.11e-05	0.002	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—HTR3A—migraine	7.07e-05	0.00199	CbGpPWpGaD
Methotrexate—Anorexia—Topiramate—migraine	7.04e-05	0.000502	CcSEcCtD
Methotrexate—ALB—Vitamin B12 Metabolism—MTHFR—migraine	7.04e-05	0.00198	CbGpPWpGaD
Methotrexate—Dizziness—Valproic Acid—migraine	7.01e-05	0.000499	CcSEcCtD
Methotrexate—Urticaria—Gabapentin—migraine	6.98e-05	0.000497	CcSEcCtD
Methotrexate—ABCC2—NRF2 pathway—TGFBR2—migraine	6.96e-05	0.00196	CbGpPWpGaD
Methotrexate—Hypersensitivity—Timolol—migraine	6.95e-05	0.000495	CcSEcCtD
Methotrexate—Body temperature increased—Gabapentin—migraine	6.94e-05	0.000495	CcSEcCtD
Methotrexate—Abdominal pain—Gabapentin—migraine	6.94e-05	0.000495	CcSEcCtD
Methotrexate—Hypotension—Topiramate—migraine	6.91e-05	0.000492	CcSEcCtD
Methotrexate—ABCB1—head—migraine	6.82e-05	0.00168	CbGeAlD
Methotrexate—Asthenia—Timolol—migraine	6.77e-05	0.000482	CcSEcCtD
Methotrexate—Vomiting—Valproic Acid—migraine	6.74e-05	0.00048	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Topiramate—migraine	6.73e-05	0.00048	CcSEcCtD
Methotrexate—Insomnia—Topiramate—migraine	6.68e-05	0.000476	CcSEcCtD
Methotrexate—Rash—Valproic Acid—migraine	6.68e-05	0.000476	CcSEcCtD
Methotrexate—Dermatitis—Valproic Acid—migraine	6.67e-05	0.000476	CcSEcCtD
Methotrexate—Pruritus—Timolol—migraine	6.67e-05	0.000476	CcSEcCtD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—HTR3A—migraine	6.65e-05	0.00187	CbGpPWpGaD
Methotrexate—Headache—Valproic Acid—migraine	6.64e-05	0.000473	CcSEcCtD
Methotrexate—Paraesthesia—Topiramate—migraine	6.64e-05	0.000473	CcSEcCtD
Methotrexate—Dyspnoea—Topiramate—migraine	6.59e-05	0.00047	CcSEcCtD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ATP1A2—migraine	6.58e-05	0.00185	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ATP1A3—migraine	6.58e-05	0.00185	CbGpPWpGaD
Methotrexate—Somnolence—Topiramate—migraine	6.57e-05	0.000468	CcSEcCtD
Methotrexate—Dyspepsia—Topiramate—migraine	6.51e-05	0.000464	CcSEcCtD
Methotrexate—Hypersensitivity—Gabapentin—migraine	6.47e-05	0.000461	CcSEcCtD
Methotrexate—FPGS—Disease—CALCA—migraine	6.47e-05	0.00182	CbGpPWpGaD
Methotrexate—ABCB1—nervous system—migraine	6.46e-05	0.0016	CbGeAlD
Methotrexate—Diarrhoea—Timolol—migraine	6.45e-05	0.00046	CcSEcCtD
Methotrexate—ABCC2—Transmembrane transport of small molecules—HTR3A—migraine	6.44e-05	0.00181	CbGpPWpGaD
Methotrexate—Decreased appetite—Topiramate—migraine	6.42e-05	0.000458	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Topiramate—migraine	6.38e-05	0.000455	CcSEcCtD
Methotrexate—Fatigue—Topiramate—migraine	6.37e-05	0.000454	CcSEcCtD
Methotrexate—ABCC1—Transmembrane transport of small molecules—HTR3A—migraine	6.36e-05	0.00179	CbGpPWpGaD
Methotrexate—Pain—Topiramate—migraine	6.32e-05	0.00045	CcSEcCtD
Methotrexate—Asthenia—Gabapentin—migraine	6.3e-05	0.000449	CcSEcCtD
Methotrexate—Nausea—Valproic Acid—migraine	6.29e-05	0.000449	CcSEcCtD
Methotrexate—Dizziness—Timolol—migraine	6.24e-05	0.000445	CcSEcCtD
Methotrexate—ABCB1—central nervous system—migraine	6.22e-05	0.00154	CbGeAlD
Methotrexate—Pruritus—Gabapentin—migraine	6.21e-05	0.000443	CcSEcCtD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—migraine	6.18e-05	0.00174	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—TGFBR2—migraine	6.13e-05	0.00173	CbGpPWpGaD
Methotrexate—Feeling abnormal—Topiramate—migraine	6.09e-05	0.000434	CcSEcCtD
Methotrexate—ABCB1—cerebellum—migraine	6.08e-05	0.0015	CbGeAlD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—HTR3A—migraine	6.05e-05	0.0017	CbGpPWpGaD
Methotrexate—Gastrointestinal pain—Topiramate—migraine	6.04e-05	0.000431	CcSEcCtD
Methotrexate—Diarrhoea—Gabapentin—migraine	6.01e-05	0.000428	CcSEcCtD
Methotrexate—Vomiting—Timolol—migraine	6e-05	0.000428	CcSEcCtD
Methotrexate—Rash—Timolol—migraine	5.95e-05	0.000424	CcSEcCtD
Methotrexate—Dermatitis—Timolol—migraine	5.94e-05	0.000424	CcSEcCtD
Methotrexate—Headache—Timolol—migraine	5.91e-05	0.000421	CcSEcCtD
Methotrexate—Urticaria—Topiramate—migraine	5.87e-05	0.000418	CcSEcCtD
Methotrexate—Abdominal pain—Topiramate—migraine	5.84e-05	0.000416	CcSEcCtD
Methotrexate—Body temperature increased—Topiramate—migraine	5.84e-05	0.000416	CcSEcCtD
Methotrexate—Dizziness—Gabapentin—migraine	5.81e-05	0.000414	CcSEcCtD
Methotrexate—ALB—Folate Metabolism—MTHFR—migraine	5.73e-05	0.00161	CbGpPWpGaD
Methotrexate—Nausea—Timolol—migraine	5.6e-05	0.000399	CcSEcCtD
Methotrexate—ABCG2—Transmembrane transport of small molecules—HTR3A—migraine	5.6e-05	0.00158	CbGpPWpGaD
Methotrexate—Vomiting—Gabapentin—migraine	5.58e-05	0.000398	CcSEcCtD
Methotrexate—Rash—Gabapentin—migraine	5.54e-05	0.000395	CcSEcCtD
Methotrexate—Dermatitis—Gabapentin—migraine	5.53e-05	0.000394	CcSEcCtD
Methotrexate—Headache—Gabapentin—migraine	5.5e-05	0.000392	CcSEcCtD
Methotrexate—Hypersensitivity—Topiramate—migraine	5.44e-05	0.000388	CcSEcCtD
Methotrexate—ALB—Transmembrane transport of small molecules—TRPM8—migraine	5.36e-05	0.00151	CbGpPWpGaD
Methotrexate—Asthenia—Topiramate—migraine	5.3e-05	0.000378	CcSEcCtD
Methotrexate—Pruritus—Topiramate—migraine	5.23e-05	0.000373	CcSEcCtD
Methotrexate—Nausea—Gabapentin—migraine	5.22e-05	0.000372	CcSEcCtD
Methotrexate—FPGS—Disease—TGFBR2—migraine	5.21e-05	0.00147	CbGpPWpGaD
Methotrexate—Diarrhoea—Topiramate—migraine	5.06e-05	0.00036	CcSEcCtD
Methotrexate—SLC46A1—Disease—CALCA—migraine	5.04e-05	0.00142	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—CACNA1A—migraine	5.04e-05	0.00142	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—MTHFR—migraine	4.98e-05	0.0014	CbGpPWpGaD
Methotrexate—ABCB1—brain—migraine	4.94e-05	0.00122	CbGeAlD
Methotrexate—AOX1—Metabolism—CACNA1A—migraine	4.92e-05	0.00139	CbGpPWpGaD
Methotrexate—Dizziness—Topiramate—migraine	4.89e-05	0.000348	CcSEcCtD
Methotrexate—MTHFR—Disease—LRP1—migraine	4.72e-05	0.00133	CbGpPWpGaD
Methotrexate—Vomiting—Topiramate—migraine	4.7e-05	0.000335	CcSEcCtD
Methotrexate—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	4.7e-05	0.00132	CbGpPWpGaD
Methotrexate—Rash—Topiramate—migraine	4.66e-05	0.000332	CcSEcCtD
Methotrexate—Dermatitis—Topiramate—migraine	4.66e-05	0.000332	CcSEcCtD
Methotrexate—Headache—Topiramate—migraine	4.63e-05	0.00033	CcSEcCtD
Methotrexate—PGD—Disease—CALCA—migraine	4.61e-05	0.0013	CbGpPWpGaD
Methotrexate—AOX1—Disease—LRP1—migraine	4.61e-05	0.0013	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—MTHFR—migraine	4.55e-05	0.00128	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CACNA1A—migraine	4.48e-05	0.00126	CbGpPWpGaD
Methotrexate—Nausea—Topiramate—migraine	4.39e-05	0.000313	CcSEcCtD
Methotrexate—FPGS—Disease—MTHFR—migraine	4.23e-05	0.00119	CbGpPWpGaD
Methotrexate—DHFR—Disease—LRP1—migraine	4.2e-05	0.00118	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—MTHFR—migraine	4.17e-05	0.00117	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CACNA1A—migraine	4.08e-05	0.00115	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—ATP1A2—migraine	4.06e-05	0.00114	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—ATP1A3—migraine	4.06e-05	0.00114	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—TGFBR2—migraine	4.06e-05	0.00114	CbGpPWpGaD
Methotrexate—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	4.02e-05	0.00113	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CACNA1A—migraine	3.91e-05	0.0011	CbGpPWpGaD
Methotrexate—PGD—Disease—TGFBR2—migraine	3.71e-05	0.00105	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CACNA1A—migraine	3.58e-05	0.00101	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	3.56e-05	0.001	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	3.56e-05	0.001	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—MTHFR—migraine	3.55e-05	0.000998	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—MTHFR—migraine	3.55e-05	0.000998	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—HTR3A—migraine	3.45e-05	0.000972	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—MTHFR—migraine	3.3e-05	0.000928	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CACNA1A—migraine	3.23e-05	0.00091	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CALCA—migraine	3.04e-05	0.000856	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—TNF—migraine	3.03e-05	0.000853	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	3.03e-05	0.000852	CbGpPWpGaD
Methotrexate—PGD—Disease—MTHFR—migraine	3.02e-05	0.000849	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—migraine	2.99e-05	0.000842	CbGpPWpGaD
Methotrexate—AOX1—Disease—CALCA—migraine	2.97e-05	0.000836	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CACNA1A—migraine	2.82e-05	0.000793	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—MTHFR—migraine	2.76e-05	0.000777	CbGpPWpGaD
Methotrexate—DHFR—Disease—CALCA—migraine	2.7e-05	0.000761	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	2.54e-05	0.000715	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CACNA1A—migraine	2.53e-05	0.000713	CbGpPWpGaD
Methotrexate—PGD—Metabolism—MTHFR—migraine	2.53e-05	0.000711	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TNF—migraine	2.47e-05	0.000694	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TGFBR2—migraine	2.45e-05	0.00069	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CACNA1A—migraine	2.41e-05	0.000678	CbGpPWpGaD
Methotrexate—AOX1—Disease—TGFBR2—migraine	2.39e-05	0.000674	CbGpPWpGaD
Methotrexate—ABCC1—Disease—LRP1—migraine	2.37e-05	0.000668	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CACNA1A—migraine	2.23e-05	0.000628	CbGpPWpGaD
Methotrexate—DHFR—Disease—TGFBR2—migraine	2.18e-05	0.000613	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—TNF—migraine	1.96e-05	0.000551	CbGpPWpGaD
Methotrexate—AOX1—Disease—MTHFR—migraine	1.94e-05	0.000547	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	1.91e-05	0.000536	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TNF—migraine	1.87e-05	0.000527	CbGpPWpGaD
Methotrexate—DHFR—Disease—MTHFR—migraine	1.77e-05	0.000498	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—MTHFR—migraine	1.63e-05	0.000458	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CALCA—migraine	1.53e-05	0.000431	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—MTHFR—migraine	1.48e-05	0.000417	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CACNA1A—migraine	1.38e-05	0.000387	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—MTHFR—migraine	1.35e-05	0.00038	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—MTHFR—migraine	1.29e-05	0.000364	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TGFBR2—migraine	1.23e-05	0.000347	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CACNA1A—migraine	1.21e-05	0.000339	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—MTHFR—migraine	1.19e-05	0.000334	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—MTHFR—migraine	1.07e-05	0.000301	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MTHFR—migraine	1e-05	0.000282	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—MTHFR—migraine	9.31e-06	0.000262	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	9.23e-06	0.00026	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—MTHFR—migraine	8.38e-06	0.000236	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—MTHFR—migraine	7.97e-06	0.000224	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—MTHFR—migraine	7.38e-06	0.000208	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MTHFR—migraine	4.55e-06	0.000128	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MTHFR—migraine	3.99e-06	0.000112	CbGpPWpGaD
